Worldwide Clinical Trials appoints new CEO Alistair Macdonald
He takes over at the CRO from Peter Benton and brings experience from GHO Capital, Syneos Health and INC Research.
List view / Grid view
He takes over at the CRO from Peter Benton and brings experience from GHO Capital, Syneos Health and INC Research.
The ICH Assembly’s decision supports progress in promoting international standards for safety assessment of medicines.
Biotech and research investments from Lilly and AstraZeneca also put on hold as pricing row rumbles on.
The novel approach could enhance quality testing applications in pharmaceutical manufacturing.
The company’s CEO says the shift will help prioritise investment into obesity and diabetes, the company’s leading therapy areas.
The innovation is set to change how eligible bladder cancer patients in the US are treated who are unresponsive to traditional therapy.
The October event at Messe Frankfurt is expected to welcome more than 63,000 pharmaceutical professionals.
Gains access to potential breakthrough atherosclerotic cardiovascular disease biologic therapy pacibekitug.
As an important policy tool, the new editions by the WHO mark a “significant” step in broadening access to new medicines with proven clinical benefits.
Deal with Kaerus Bioscience for KER-0193 could be worth $450m to the UK-based biotech.
The regulator’s new principles aim to ease the pathway to regulatory approval for rare disease drug developers in the US.
Says the Bay Area building’s digital infrastructure will make it one of biopharma’s leading artificial intelligence-powered centres.
CE mark for Contivue platform supports its ambitions for Susvimo in age-related macular degeneration (AMD).
The new Thousand Oaks, California facility will incorporate advanced automation and digital capabilities.
David Weinreich will also serve as its Chief Medical Officer and arrives at the German pharmaceutical group with experience from Amgen, Bayer and Regeneron.